Related references
Note: Only part of the references are listed.Metformin ameliorates ROS-p53-collagen axis of fibrosis and dyslipidemia in type 2 diabetes mellitus-induced left ventricular injury
Bahjat Al-Ani et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2023)
Toxicological effects of deltamethrin on quail cerebrum: Weakened antioxidant defense and enhanced apoptosis
Jiayi Li et al.
ENVIRONMENTAL POLLUTION (2021)
Hexavalent chromium induced heart dysfunction via Sesn2-mediated impairment of mitochondrial function and energy supply
Daqian Yang et al.
CHEMOSPHERE (2021)
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
M. Arow et al.
CARDIOVASCULAR DIABETOLOGY (2020)
The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis
Rosalie A. Scholtes et al.
DIABETES OBESITY & METABOLISM (2020)
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury
Sarayut Lahnwong et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte
Tiziana Filardi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Anastasios Tentolouris et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study
Yohei Fujita et al.
SCIENTIFIC REPORTS (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors
Sarayut Lahnwong et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity
Guanghong Jia et al.
CIRCULATION RESEARCH (2018)
Cardioprotective Mechanisms of Exenatide in Isoprenaline-induced Myocardial Infarction: Novel Effects on Myocardial α-Estrogen Receptor Expression and IGF-1/IGF-2 System
Ahmed M. Darwesh et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)
Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis
Junlian Gu et al.
CELL DEATH & DISEASE (2018)
The PI3K/AKT pathway in obesity and type 2 diabetes
Xingjun Huang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats
Aysegul Durak et al.
CARDIOVASCULAR DIABETOLOGY (2018)
An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy
Giacomo Frati et al.
CARDIOVASCULAR RESEARCH (2017)
Acute SGLT inhibition normalizes O-2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats
Julie O'Neill et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Erythropoietin exerts cell protective effect by activating PI3K/Akt and MAPK pathways in C6 Cells
Min-Soo Kwon et al.
NEUROLOGICAL RESEARCH (2014)
Protein kinase RNA- like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)- mediated endoplasmic reticulum stress- induced apoptosis in diabetic cardiomyopathy
Zhong-Wei Liu et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Interleukin-1β induces a reversible cardiomyopathy in the mouse
Benjamin W. Van Tassell et al.
INFLAMMATION RESEARCH (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
Chun-jun Li et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Cellular mechanisms of cardiomyopathy
Pamela A. Harvey et al.
JOURNAL OF CELL BIOLOGY (2011)
Erythropoietin-Induced Activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK Pathways Promotes Malignant Cell Behavior in a Modified Breast Cancer Cell Line
Zhanzhong Shi et al.
MOLECULAR CANCER RESEARCH (2010)
Diastolic Dysfunction and Its Histopathological Correlation in Obstructive Hypertrophic Cardiomyopathy in Children and Adolescents
Shaji C. Menon et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2009)
Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus
A Symeonidis et al.
ANNALS OF HEMATOLOGY (2006)
Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography
Y Koga et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2004)
Activation of the mitogen-activated protein kinases Erk1/2 by erythropoietin receptor via a Gi protein βγ-subunit-initiated pathway
C Guillard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy
EK Podewski et al.
CIRCULATION (2003)
Share Paper
